The Tissue Culture Shared Resource (TCSR) is an integral part ofthe Lombardi Comprehensive Cancer Center (Lombardi) research activities. The Cancer Center Support Grant (CCSG) has provided funding to the facility since 1993. Dr. Bassem R. Haddad has served as the Resource Director since January 2002. The role of the Resource is to assist investigators with all of the tissue culture related aspects of their work and to maintain the Lombardi cell line repository. To this end, the TCSR provides consultation, facilities and services to a diverse group of investigators involved in cancer research. Specifically, the TCSR: ? Maintains the Lombardi cell line repository and provides frozen vials or live cultures of these lines to investigators. ? Equips, monitors, stocks, and services four separate shared tissue culture laboratories for the use of investigators who do not have facilities to perform tissue culture in their own laboratories or who need additional tissue culture space. ? Prepares, tests, and supplies tissue culture reagents ofthe highest quality that have been specifically tested for suitability in the relevant systems, as inexpensively as possible. ? Provides mycoplasma testing and genetic fingerprinting of cells. ? Provides expert consultation regarding the use of tissue culture techniques in cancer research and provides training to investigators at all levels in the use of this technology. ? Provides a safe, secure cryo-storage facility for investigators to keep frozen stocks of their cancer cell lines. ? Provides a B-cell transformation service to facilitate cancer genetics studies. The Resource continues to be heavily utilized by a large number of Lombardi members: of 67 users in 2008, 57 were Lombardi members from five programs, and 50 of these had peer-reviewed grants. In addition, the TCSR provides laboratory services to five other Lombardi Shared Resources.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Bae, Woo Kyun; Yoo, Kyung Hyun; Lee, Ji Shin et al. (2015) The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog 54:1172-80
Adams, Inez; Christopher, Juleen; Williams, Karen Patricia et al. (2015) What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. J Cancer Educ 30:344-52
Butrick, Morgan; Kelly, Scott; Peshkin, Beth N et al. (2015) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17:467-75
London, Laricca; Hurtado-de-Mendoza, Alejandra; Song, Minna et al. (2015) Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74-80
Mays, Darren; Niaura, Raymond S; Evans, W Douglas et al. (2015) Cigarette packaging and health warnings: the impact of plain packaging and message framing on young smokers. Tob Control 24:e87-92
Zhi, Xiuling; Lin, Ling; Yang, Shaoxian et al. (2015) ?II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology 61:598-612
Rush, Christina L; Darling, Margaret; Elliott, Maria Gloria et al. (2015) Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res 24:1107-18
Heckler, Mary Mazzotta; Riggins, Rebecca B (2015) ERR? splice variants differentially regulate cell cycle progression. Cell Cycle 14:31-45
Kim, B; Wang, S; Lee, J M et al. (2015) Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy. Oncogene 34:1083-93
Tong, Angie; Kelly, Scott; Nusbaum, Rachel et al. (2015) Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology 24:33-9

Showing the most recent 10 out of 544 publications